Evidence map›Paper›PMID 42670586›Full record

ArticleBrain and behavior2026

Associations of Weight and Glucose Levels With Myasthenia Gravis: A Two-Step, Two-Sample Mendelian Randomization and Retrospective Case-Control Study.

Hai Lin, Jinrong Zhu, Xi Qu, Shenyi Lin, Shengqi Li, Yukai Wang, Jiaxuan Chen, Ruting Wei, Yanyi Pan, Xinran Li and 3 more

Abstract read
In one paragraph

Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hai Lin *Department of Endocrinology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jinrong Zhu *Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xi Qu *Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Shenyi LinDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Shengqi LiDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yukai WangDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jiaxuan ChenDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Ruting WeiDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yanyi PanDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xinran LiDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Ruizi XuDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Suwen HuangDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID https://orcid.org/0000-0002-1407-4276
Yiyun WengDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies suggested links between obesity, glucose regulation, and autoimmune diseases, but the associations of weight and glucose levels with myasthenia gravis (MG) remain uncertain. We examined these associations and a potential indirect pathway through glucose levels.

objectiveWe investigated the associations of weight and glucose levels with MG risk using Mendelian randomization (MR) and a retrospective case-control study.

methodsWe conducted two-sample MR analyses using genome-wide association study summary statistics from European populations. The clinical component retrospectively included patients with MG and healthy controls and used propensity-score matching and logistic regression.

resultsThe MR analyses suggested associations among genetically predicted weight, glucose levels, and MG risk. They also yielded a small indirect estimate through glucose levels that was opposite in direction to the direct and total effects. This opposing-direction indirect estimate was sensitive to the inferential method and was not observed in the retrospective case-control analysis. In the clinical analysis, MG cases had higher weight and lower glucose levels than controls, and both variables were associated with MG status.

conclusionTwo-sample MR suggested that genetically predicted higher weight was associated with higher odds of MG, whereas genetically predicted higher glucose levels were associated with lower odds of MG. The retrospective case-control analysis showed directionally similar associations for measured weight and fasting glucose, but the indirect pathway suggested by MR was not observed in the clinical analysis.

Indexed as

Blood GlucoseBody WeightMyasthenia GravisCase-Control StudiesFemaleGenome-Wide Association StudyHumansMaleMendelian Randomization AnalysisRetrospective StudiesBlood GlucoseglucoseMendelian randomizationmyasthenia gravisweight

Identifiers

PMID42670586
PMCPMC13527523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.